patkanynyuleger1

We believe that we can change the monoclonal antibody development in most casee even if you have a target that seems impossible.

This technology was patented in 2007 and from that point on the company had two main characteristics: developing custom made antibodies and developing transgenic animals.

Our goal is to support R&D of pharma companies and academics to improve their efficiency in identifying new therapeutic targets and therapeutic candidates. 

All leaders are scientist who have worked in the field for more than 20 years

Our CEO is a well established highly rated and published scientist who not only knows the in and outs of immunology but is a businessman

We understand the high pressure which is on your shoulder

We want your project to succeed, and help you plan it

We have facilities and we understand that some scientific projects need more planning

We send you regular reports, and updates 

We tailor your project as you would like and we help you to decide which way to go

We understand that how much work was put in to a scientific project and how it can affect each step 

USA China Japan England Netherlands France Spain Italy Portugal Israel Greece Switzerland Germany Czech Republic Slovakia Austria

1.

Contact form fill out

2.

Management reply

3.

TC appointment set up (if needed)

4.

Project planning with lead scientists

5.

Contract

6.

Start of your project

Start it

We use HTTP cookies on our pages for better operation.